Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review Aarkstore Enterpr

Summary

Benitec Biopharma Limited (Benitec), formerly Benitec Ltd., is a research focused biotechnology offerings provider. The company is engaged in the development of innovative pharmaceuticals for the treatment of serious life threatening diseases. The company has developed its proprietary DNA-directed RNA interference (ddRNAi) technology and siRNA technology for the development of human therapeutics to precisely destroy RNA viruses and silence the expression of defective genes. Its therapeutic programs targets the areas such as HIV/AIDS, Hepatitis B, infectious diseases, neurological disorders, cancer and autoimmune diseases. Benitec develops treatments for Hepatitis C and HIV in collaboration with some pharmaceutical companies. The company is headquartered in Melbourne, Australia.


Benitec Biopharma Limited Key Recent Developments

Aug 08, 2011: Benitec Patent Estate Strengthens Further With Another Gene Silencing Graham Family Patent Allowed In US Aug 05, 2011: Benitec Moves Operations To Sydney, Replaces CFO Jul 27, 2011: Benitec Announces Allowance Of Another Key US Graham Family Patent May 25, 2011: Benitec Receives RNA Interference Patent In Japan Mar 22, 2011: Benitec Provides RNAi Patent Update

For more information, please visit:



Or email us at or call +918149852585

More reports

Alltech Inc. - Strategic SWOT Analysis Review Zhejiang Hisun Pharmaceutical Co. Ltd. (600267) - Financial and Strategic SWOT Analysis Review Clovis Oncology, Inc. (CLVS) - Financial and Strategic SWOT Analysis Review ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review Cephalon, Inc. - Strategic SWOT Analysis Review Chr. Hansen Holding AS (CHR) - Financial and Strategic SWOT Analysis Review H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review RuralMetro Corporation (RURL) - Financial and Strategic SWOT Analysis Review Genmab AS (GEN) - Financial and Strategic SWOT Analysis Review Hexima Limited - Strategic SWOT Analysis Review Veloxis Pharmaceuticals AS (VELO) - Financial and Strategic SWOT Analysis Review Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review Novo Nordisk AS (NOVO B) - Financial and Strategic SWOT Analysis Review JCR Pharmaceuticals Co., Ltd. (4552) - Financial and Strategic SWOT Analysis Review Evocutis PLC (SYN) - Financial and Strategic SWOT Analysis Review OraSolv AB (OS) - Financial and Strategic SWOT Analysis Review China Pharma Holdings, Inc. (CPHI) - Financial and Strategic SWOT Analysis Review

Aarkstore Enterprise

Tel : +912227453309

Mobile No:+08149852585

Email :

Website :

Blog:

Follow us on twitter: